在 英语 中使用 Secondary endpoints 的示例及其翻译为 中文
{-}
-
Political
-
Ecclesiastic
-
Programming
However, encouraging single-agent CYRAMZA activity was observed, with meaningful improvements in key secondary endpoints as well as within certain patient subgroups.
Additionally, patients treated with galcanezumab experienced statistically significant improvement compared to placebo on several pre-specified secondary endpoints, including response rates and measures of daily activities.
In two identically-designed Phase 3 clinical trials, ADAPT 1 and ADAPT 2, avatrombopag met all primary and secondary endpoints with high statistical significance.
Based on initial topline analyses, the trial met its primary and secondary endpoints in a“highly statistically significant manner”(p<0.0001 for all endpoints). .
The secondary endpoint was remission rate, defined as MADRS score of 12.
The key secondary endpoint is cardiovascular death, MI or stroke.
The predefined secondary endpoint was symptom improvement rate at week 12.
Safety was the secondary endpoint.
The primary endpoint for the trial is PFS and the secondary endpoint is OS.
Overall survival(OS) was a secondary endpoint on this study.
The effect on breast cancer incidence was a secondary endpoint.
The primary endpoint for the trial is PFS and the secondary endpoint is OS.
The primary endpoint is progression-free survival and the key secondary endpoint is overall survival.
The primary endpoint for the trial is PFS and the secondary endpoint is OS.
Primary endpoints were safety and tolerability, secondary endpoint was the induction of WHO-recommended level of virus neutralizing antibody titers.
The primary endpoint is engraftment after transplantation and the secondary endpoint is transplant-related safety and tolerability.
A significant improvement in overall survival(a key secondary endpoint), reducing the risk of death by 19%.
The dual primary endpoints of the study were OS and PFS, and the key secondary endpoint was ORR.
The Phase II study was not statistically powered to show a difference in the secondary endpoint of survival.
The study was event-driven and continued until at least 1,630 patients experienced a key secondary endpoint.